Martin F. Fey

Martin F. Fey

Auto-generated profile, based on publicly available information

Martin F. Fey

Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2009 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
I(International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
OPOlivia Pagani
Olivia Pagani
KPKaren N. Price
Karen N. Price
RGRichard D. Gelber
Richard D. Gelber
MCMonica Castiglione-Gertsch
Monica Castiglione-Gertsch
AGAron Goldhirsch
Aron Goldhirsch

21 November 2005 in Oncogene
Verified
Journal Article
Closed access
CBC Britschgi
C Britschgi
MRM Rizzi
M Rizzi
TGT J Grob
T J Grob
Mario P. TschanMario P. Tschan
Mario P. Tschan
BHB Hügli
B Hügli
MFM F Fey
M F Fey

31 March 2010 in Leukemia Research
Verified
Journal Article
Closed access
Mario P. TschanMario P. Tschan
Mario P. Tschan
DSDeborah Shan
Deborah Shan
JLJudith Laedrach
Judith Laedrach
MEMarianne Eyholzer
Marianne Eyholzer
ELElisabeth Oppliger Leibundgut
Elisabeth Oppliger Leibundgut
MFMartin F. Fey
Martin F. Fey

1 April 2003 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
NLNicolas Leupin
Nicolas Leupin
BCBruno Cenni
Bruno Cenni
UNUrban Novak
Urban Novak
BHBarbary Hügli
Barbary Hügli
HGHans U. Graber
Hans U. Graber
MFMartin F. Fey
Martin F. Fey
Summary. One fifth of B‐cell chronic lymphocytic leukaemia (B‐CLL) patients exhibit loss of heterozygosity (LOH) at 10q23.3, the site of the tumour suppressor PTEN. Microsatellite markers mapped complete LOH to 10q23.3 in 2/41 B‐CLL (5%) and allelic imbalances in 6/41 (15%). No PTEN gene mutations were found. PTEN protein expression was not detected in 11 B‐CLL (28%), and was reduced in eight patients (20%). LOH or allelic imbalances at 10q23.3 were fairly frequent in B‐CLL, but did not encompass the PTEN gene. Nevertheless, PTEN protein may be absent in B‐CLL with a normal PTEN genotype, suggesting a role of this phosphatase in the molecular pathology of B‐CLL.

1 July 2001 in Annals of Oncology
Verified
Journal Article
Open access
PDF file
UNUrban Novak
Urban Novak
TGT. J. Grob
T. J. Grob
GBG. Baskaynak
G. Baskaynak
UPU. R. Peters
U. R. Peters
SAS. Aebi
S. Aebi
MFM. F. Fey
M. F. Fey
The p73 protein shares structural and functional similarities with the tumour-suppressor p53, but its role in neoplastic transformation is unknown.

25 October 2008 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
FGfor the International Breast Cancer Study Group
for the International Breast Cancer Study Group
OPOlivia Pagani
Olivia Pagani
SGShari Gelber
Shari Gelber
ESEdda Simoncini
Edda Simoncini
MCMonica Castiglione-Gertsch
Monica Castiglione-Gertsch
AGAron Goldhirsch
Aron Goldhirsch